Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04787289
Title A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.